J

Julie E. Ledgerwood

Vaccine Research Institute of San Diego

ORCID: 0000-0002-2047-6052

170 papers and 23.6k citations.

PubIndex Score97Top 3%How it's scored

170Publications

23.6kTotal Citations

First senior author: 2010

Top publicationsby citations

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021

Cited by 661

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, Myron S. Cohen, Nyaradzo Mgodi et al.|New England Journal of Medicine|2021

Cited by 540

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

Kenneth H. Mayer, Kelly E. Seaton, Yunda Huang et al.|PLoS Medicine|2017

Cited by 132

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

Myra Happe, Jamie Sanders, Amelia R. Hofstetter et al.|npj Vaccines|2024

Cited by 19

Indexing the rest of 170 publications…